Latest news
The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today - inklinkl · Mon, 03 Aug 2026 20:54:00 GMTAstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus - BenzingaBenzinga · Mon, 03 Aug 2026 17:13:39 GMTFDA Approval Nearly Doubles Eligible Patient Pool For Novartis' Pluvicto - BenzingaBenzinga · Mon, 03 Aug 2026 16:56:48 GMTSupernus to Combine with Indivior To Form CNS Biopharmaceutical Leader with Potential $2 Billion in Revenue - BenzingaBenzinga · Mon, 03 Aug 2026 14:44:26 GMTAstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Session - BenzingaBenzinga · Mon, 03 Aug 2026 12:01:17 GMTWhy Atkore Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket - BenzingaBenzinga · Mon, 03 Aug 2026 08:33:38 GMTAstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - BenzingaBenzinga · Sun, 02 Aug 2026 20:12:52 GMTDow Gains Over 250 Points Amid Lower Oil Prices: Investor Sentiment Weakens, Greed Index Remains In ‘Fear’ Zone - BenzingaBenzinga · Tue, 28 Jul 2026 08:00:10 GMT